PLA2G4B antibody - N-terminal region (ARP35757_P050)
- Known as:
- PLA2G4B (anti-) - N-terminal region (ARP35757_P050)
- Catalog number:
- arp35757_p050
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Aviva Systems Biology
- Gene target:
- PLA2G4B antibody - N-terminal region (ARP35757_P050)
Related genes to: PLA2G4B antibody - N-terminal region (ARP35757_P050)
- Gene:
- PLA2G4B NIH gene
- Name:
- phospholipase A2 group IVB
- Previous symbol:
- -
- Synonyms:
- cPLA2-beta, HsT16992
- Chromosome:
- 15q15.1
- Locus Type:
- gene with protein product
- Date approved:
- 1998-11-20
- Date modifiied:
- 2016-10-05
Related products to: PLA2G4B antibody - N-terminal region (ARP35757_P050)
Related articles to: PLA2G4B antibody - N-terminal region (ARP35757_P050)
- Pediatric bone sarcomas, including osteosarcoma (OS) and Ewing sarcoma (ES), are aggressive malignancies with poor prognosis in the metastatic stage. Oxylipins, bioactive lipid mediators derived from polyunsaturated fatty acids (PUFAs), play a crucial role in inflammation, immunity, and cancer progression; however, their systemic profiles in pediatric sarcomas remain unexplored. - Source: PubMed
Publication date: 2026/05/23
Chistyakov D VNikolskaya A IGorbatenko V OGoriainov S VPrishchep P LKuzmin Yu BAlferov A AKuznetsov I NVarfolomeeva S RStilidi I SKushlinskii N ESergeeva M G - The gut-skin axis represents a critical but poorly understood pathway in atopic dermatitis (AD) pathogenesis. This study aimed to establish causal relationships between gut microbiota and AD risk while identifying key molecular bridges and therapeutic targets. We integrated multiple analytical approaches, including single-cell RNA sequencing analysis of skin biopsies from five AD patients and four healthy controls, intercellular communication network analysis, pseudotime trajectory inference, reverse drug prediction, molecular docking, and molecular dynamics simulations. Analysis revealed increased keratinocyte heterogeneity and enhanced immune cell communication in atopic dermatitis (AD) samples. Intersection analysis between gut microbial metabolite-associated genes and skin pathology-related genes identified seven key bridging genes (, , , , , ). Functional annotation indicated that these genes are primarily involved in vitamin precursor metabolism, suggesting that the group influences AD pathogenesis mainly through vitamin precursor-mediated pathways that regulate systemic immune responses. Pseudotime trajectory analysis demonstrated dynamic temporal gene expression patterns during disease progression. Molecular docking revealed an unexpectedly high-affinity binding between methotrexate and (binding energy = -10.4 kcal/mol), which exceeded its binding affinity for the classical target (-7.5 kcal/mol). Molecular dynamics simulations further confirmed the stable binding conformation of the protein-ligand complexes. This study provides mechanistic insights into how the group influences atopic dermatitis through vitamin precursor-mediated systemic immune modulation and identifies as a novel therapeutic target. The findings provide mechanistic insights into the gut-skin axis and support developing precision medicine approaches integrating microbiome interventions with targeted pharmacotherapy for AD management. - Source: PubMed
Publication date: 2025/12/05
Cao FangLiu AoNanTong JiaoyangGuo CuiZhang HuiPang YaobinTang KexinYu QianyingGuo Jing - Ferroptosis and mitochondrial metabolism are closely associated with the pathological processes of various diseases. However, the role of ferroptosis-related genes (FRGs) and mitochondrial metabolism-related genes (MMRGs) in poor ovarian response (POR) remains unexplored. - Source: PubMed
Publication date: 2025/11/14
Cai YunyingLin NaYin YijieTian MeiWu ZeSu Heng - Type 2 diabetes mellitus (T2DM) is a metabolic disorder caused by insufficient insulin secretion from pancreatic beta cells or reduced insulin sensitivity in peripheral tissues. It has a high clinical incidence rate and can lead to various complications, significantly impacting patients' quality of life and lifespan. Syringin is a natural active compound, and studies have shown that it has certain therapeutic effects on diabetes, but its mechanism of action remains unclear. - Source: PubMed
Publication date: 2025/10/21
Wan ChunleiSun SiyuDu YuqingHan YuxingLi XueyingYang YueCao JianingMiu JinChen PengZhang YuexinLiu ShaoboZhang Lei - Ageing, marked by cumulative molecular damage, now leaves most adults spending nearly a decade in poor health. To date, no therapies directly target the ageing process. We performed a large-scale genome-wide association study to identify potential drug targets for extending health span. - Source: PubMed
Publication date: 2025/09/26
Cai ZhikangYang YueQu PengFu SensongLi Xu